An Introduction

The munKNEE Canadian Cannabis LPs Portfolio, consisting of the 5 largest Canadian cannabis licensed producers, jumped 52% on Tuesday, April 30th, with the news that the DEA planned to follow through on the September, 2023, recommendation from the Department of Health and Human Services that cannabis be reclassified from that of a Schedule I drug to a less stringently regulated Schedule III drug. Since then, however, the Portfolio has  dropped by 20.7% although it advanced 14.1% this week.

Below are the details by constituent, in descending order, and any recent pertinent news:

1. Canopy Growth (CGC): up 19.9% this week; still down 27.1% MTD
   • Company Description:
     • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.
     • It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. Source
   • Latest news, commentary and/or analysis:
     • Weed stocks pop as Biden backs marijuana reclassification
2. Aurora (ACB): up 14.1% this week; still down 20.0% MTD
   • Company Description:
     • Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
     • It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada and is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; the supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products.
     • In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates.
     • Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. Source
   • Latest news, commentary and/or analysis:
     • This Is How Marijuana Stocks Will Be Impacted By Reform In 2024
3. Organigram (OGI): up 13.6% this week; still down 10.3% MTD
   • Company Description:
     • Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada.
     • It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis....
     • The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis.
     • It sells its products through online, as well as consumer channels. Source
   • Latest news, commentary and/or analysis:
     • Organigram Reports Second Quarter Fiscal 2024 Results
4. Cronos (CRON): up 4.3% this week; still down 1.4% MTD
   • Company Description:
     • Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.
     • It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Source
   • Latest news, commentary and/or analysis:
     • Cronos Group Reports 2024 First Quarter Results
5. Tilray (TLRY): up 2.1% this week; still down 19.8% MTD
   • Company Description:
     • Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
     • The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business.
     • It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products.
     • In addition, the company...sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. Source
   • Latest news, commentary and/or analysis:
     • Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective

Average: Portfolio up 14.1% this week; still down 20.7% MTD

More By This Author:

AI Small Cap Stocks Portfolio Up 3% W/e May 10th; Still Down 26% YTD
AYR Wellness' Q1 Financials Reveal 94% Reduction In Net Loss
All Cresco Labs' QI Financial Metrics Down Except SG&A